fluorometholone has been researched along with ketorolac in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S; McDonnell, PJ; Phillips, AF; Seitz, B; Wee, WR | 1 |
| Breusegem, C; Fieuws, S; Renier, C; Spielberg, L; Stalmans, I; Van de Veire, S; Van Ginderdeuren, R; Vandewalle, E; Zeyen, T | 1 |
| Chuck, RS; Zhang, C; Zhu, L | 1 |
| Celik, T; Turkoglu, EB | 1 |
| Bourke, RD; Phillis, CA | 1 |
2 trial(s) available for fluorometholone and ketorolac
| Article | Year |
|---|---|
Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Conjunctiva; Double-Blind Method; Female; Fibrosis; Fluorometholone; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Ketorolac; Male; Middle Aged; Mitomycin; Postoperative Complications; Preoperative Care; Prospective Studies; Trabeculectomy; Treatment Outcome | 2010 |
Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Dibenzoxepins; Drug Combinations; Female; Fluorometholone; Histamine H1 Antagonists, Non-Sedating; Humans; Ketorolac; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Placebos; Seasons; Treatment Outcome; Young Adult | 2014 |
3 other study(ies) available for fluorometholone and ketorolac
| Article | Year |
|---|---|
Effect of diclofenac, ketorolac, and fluorometholone on arachidonic acid metabolites following excimer laser corneal surgery.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Chemotaxis, Leukocyte; Cornea; Diclofenac; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Fluorometholone; Ketorolac; Lasers, Excimer; Leukotriene B4; Neutrophils; Ophthalmic Solutions; Photorefractive Keratectomy; Rabbits; Tolmetin | 1996 |
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Botulinum Toxins; Botulinum Toxins, Type A; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Glucocorticoids; Interleukin-1beta; Ketorolac; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Phenylacetates; Tears; Tumor Necrosis Factor-alpha | 2012 |
Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Blood-Retinal Barrier; Corneal Pachymetry; Drug Therapy, Combination; Female; Fluorescein Angiography; Fluorometholone; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Ketorolac; Laser Therapy; Retinal Neovascularization; Subretinal Fluid; Tomography, Optical Coherence; Trabeculectomy; Visual Acuity | 2016 |